<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

Strategy, Investment and
Partnering for Life Science
Executive Leaders
February 5-6, 2019 | etc.venues 200 Aldersgate, London
#LSXWORLD

DOWNLOAD THE BROCHURE
REGISTER NOW
Senior Executives
 
700+
Investors & Pharma
 
300+
Speakers
 
175+
Pre-Arranged Meetings
 
1500+
Company Showcases
 
75+

What is the LSX World Congress?

The 5th annual LSX World Congress is the new name for the Biotech and Money / Medtech and Money World Congress. The name may have changed, but it retains its core offering for the C-suite of the global life science industry.

The LSX World Congress is a high-calibre, senior executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science executives need to enable more effective investment, planning and strategic growth within their businesses.

With a relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, the LSX World Congress brings together the people that matter to the future of healthcare.

In February 2019, LSX World Congress brings together Biotech, Medtech, Healthtech and Deeptech all under one roof. It’s an incredible 2-days that you’ll want to be part of.

Strategy icons8-blockchain-technology-80

STRATEGY

Investors icons8-coins-80   

INVESTMENT

Partnership icons8-meeting-80

PARTNERING

Deeptech icons8-blockchain-80

Innovation

Innovation icons8-innovation-80

IDEAS

Speakers icons8-commercial-80

KEYNOTES

Forums icons8-teamwork-80

P2P FORUMS

Showcases

Showcases

Exhibition icons8-exhibitor-80

EXHIBITION

Meetings icons8-meeting-room-80

MEETINGS

ENQUIRE HERE


Confirmed Speakers Include:


ALESSIO BEVERINA

ALESSIO BEVERINA

Founder and Managing Partner
Panakes Partners
JASPER BOS

JASPER BOS

Vice President
M Ventures
THOMAS BURT

THOMAS BURT

Partner
Crossover Fund, Sofinnova
Francesco De Rubertis, Co-Founder and Partner, Medicxi

Francesco De Rubertis

Co-Founder and Partner
Medicxi
Miriam Frieden

Miriam Frieden

VP of Search & Evaluation
Novo Nordisk
Martin Frost, CEO, CMR Surgical

Martin Frost

CEO
CMR Surgical
 JENS GRUEGER SVP Global Access ROCHE

JENS GRUEGER

SVP Global Access
Roche
TIM HAINES

TIM HAINES

Managing Partner
Abingworth
Deborah Harland

Deborah Harland

Partner
SR One
Jens Holstein

Jens Holstein

CFO
Morphosys
JACKIE HUNTER Chief Executive BenevolentBio

JACKIE HUNTER

Chief Executive
BenevolentBio
THOMAS LONNGREN Former Head of EMA and Senior Advisor NDA GROUP

Thomas Lonngren

Former head of EMA and Senior Advisor
NDA Group
SEAN MARETT CBO & CCO BioNTech

SEAN MARETT

CBO & CCO
BioNTech
Søren Møller

Søren Møller

Managing Partner
Novo Seeds
GERALDINE O’KEEFFE Partner LSP

GERALDINE O’KEEFFE

Partner
LSP
Sander Slootweg, Managing Partner, Forbion

Sander Slootweg

Managing Partner
Forbion Capital Partners

Meet our partners

Allen & Overy
Bird&Bird.jpg
Citi 300x150.png
CMS Cameron McKenna Nabarro Olswang LLP
Covington
Lilly-1.png
Goodwin
illumina-logo.svg
Leerink
Medtronic
MSD
Nasdaq
NDA 300x200.jpg
White & Case 300x150-853208-edited.png
LSX Congress USA

Hear from past attendees

"Great partnering system"
Nuritas
"Good quality panel debates"
Sanara Ventures
"Top level participants"
Lonza
"I enjoyed and learned a lot"
Destiny Pharma

Never miss an update

Sign up to event updates to hear about new speakers, promotions, conference news and networking events.